FORMELA JEAN FRANCOIS sold KRRO

September 14, 2026 · Form 4 insider transaction

FORMELA JEAN FRANCOIS sold 31,888 shares of Korro Bio, Inc. at $14.12 per share, a transaction worth $450.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
31,888
Price
$14.12
Total value
$450.3K
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 14, 2026
Filing dateSeptember 15, 2026
Shares owned after640,610
OwnershipIndirect
10b5-1 planYes
AmendedNo

Footnotes

Shares were sold pursuant to a Rule 10b5-1 trading plan on April 8, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.95 to $14.59 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.; These shares are held directly by Atlas Venture Fund XI, L.P. ("Atlas XI"). Atlas Venture Associates XI, L.P. ("AVA XI LP") is the general partner of Atlas XI. Atlas Venture Associates XI, LLC ("AVA XI LLC") is the general partner of AVA XI LP. The Reporting Person is a member of AVA XI LLC and disclaims Section 16 beneficial ownership of such shares, except to the extent of his pecuniary interest therein, if any.

View the original Form 4 on SEC EDGAR